Ingredients/Content

Active ingredients: Amoxycillin 500mg in 1 tablet + Pot.Clavulanate 125mg

Efficacy/Effectiveness

This product (Amoxyheal-CV) is a combination antibiotic formulation. It contains the active ingredients amoxicillin and potassium clavulanate.

Amoxicillin Amoxycin 875 mg + Clavulanate Pot. Clavulanate 125 mg

This product (Amoxyheal-CV) is a drug that kills bacteria and treats infections.

Effective Mycobacteria *S.aureus, *S.aureus, *S.aureus, Streptococcus pyogenes (group A-beta hemolytic), Streptococcus pneumoniae, Streptococcus viridans, Enterococcus phycalis, Corynebacterium, anthrax, Listeria monocytogenes, Clostridium, Peptococcus, *E. coli, *Proteus mirabilis, *Proteus bulgaris, *Clevciella, *Salmonella, *Shigella, Bordetella pertussis, *Yersinia enterocolitica, Burusella, Meningitis, *G.cateralis, *Influenza, Animal Pasteurellosis Pathogens, Pseudocampylobacterium, Cholera, *Bacteroidis, *Bacteroides (including ampicillin and amoxicillin-resistant beta-lactamase-producing strains) Indication – acute and chronic bronchitis, macrophaly and bronchial pneumonia, pyothorax, pulmonary abscess, tonsillitis, sinusitis – middle ear inflammation, pelvic infections, urethritis, pyelonephritis – abscesses, soft tissue inflammation, wound myelitis – dental infection

Usage/Capacity

The dose of this drug is considered according to the patient's age, weight, and kidney function and the severity of infection. It is administered early in the meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin/clavulanic acid is optimized when administered early in the meal. – Adults and children over 12 years of age or over or over 40 kg in weight: 250 mg/125 mg once as amoxicillin/clavulanic acid, oral administration every 8 hours three times a day, and can be increased to 500 mg/125 mg once as potassium amoxicillin/clavulanic acid in case of severe and respiratory infections. – In the case of renal impairment, it increases or decreases appropriately according to the creatinine clearance rate.

Adult: Dose control is based on the maximum recommended dose of amoxicillin. For patients with creatinine clearance (CrCl) of 30 mL/min or more, dose control is not required.

Precautions for use

In order to prevent the expression of bacteria resistant to amoxicillin (resistance), it is recommended to administer only the minimum period required for treatment after confirming that it is a strain that responds to amoxicillin (sensitivity).

Non-susceptible bacteria and fungi may overgrow due to repeated administration and long-term use, so if mycosis* occurs, stop administration and take appropriate treatment. Observe amoxicillin and clavulanic acid combinations if administered for more than 14 days.

Severe and fatal hypersensitivity reactions can occur in patients given penicillin antibiotics, including amoxicillin, and these reactions are likely to occur in patients with a history of penicillin hypersensitivity or allergic sensitivity.

In order to predict these responses, it is recommended that you consult a medical professional sufficiently and conduct a skin response test in advance.

In addition, even after administration, first aid should be prepared and sufficiently observed in preparation for shock.

Care should be taken when administering amoxicillin in patients whose own, parents, or siblings are prone to allergic symptoms.

Patients with diarrhea during or after antibiotic use may suspect the occurrence of pseudomembranous colitis.

If long-term or severe diarrhea occurs, or abdominal cramps occur, the use of amoxicillin should be stopped immediately and further investigation should be conducted.

Since it is excreted in the kidneys, care such as adjusting the dose is required when renal function is impaired.

Care should be taken when administering to patients with poor oral intake, parenteral nutritional patients, the elderly, and patients with poor systemic conditions.

When administering a high dose of amoxicillin, drink enough water to prevent crystalline urination that causes crystals in the urine.

Amoxicillin can affect some clinical test values. When a urinary sugar test produces false positive results or is administered to a pregnant woman, the female hormone test value may be temporarily reduced.

In addition, in the Coombs test, which tests diseases or clinical conditions related to red blood cells and blood, a combination of clavulanic acid may show false positives. When conducting clinical tests while taking amoxicillin, the medical staff should be notified in advance of the drug being taken.

Care should be taken because symptoms may worsen when administered to patients with liver disorders.

Regular liver and renal function tests are recommended for long-term administration.

When administering a combination of amoxicillin and clavulanic acid orally, caution is required because the degree of drug absorption may change in patients with digestive diseases accompanied by vomiting or diarrhea.

Storage method

Store at room temperature (1-30℃), shielded airtight container

etc

We encourage you to consult with your doctor before your personal income to gain sufficient knowledge of your medicines.

Manufacturer

Healing Pharma